Multidrug chemotherapy in the treatment of non-elderly patients with hormone-refractory prostatic carcinoma. A phase II study. North-Eastern Italian Oncology Group (GOCCNE).

@article{Veronesi1996MultidrugCI,
  title={Multidrug chemotherapy in the treatment of non-elderly patients with hormone-refractory prostatic carcinoma. A phase II study. North-Eastern Italian Oncology Group (GOCCNE).},
  author={Andrea Veronesi and Giuseppe Lo Re and S Foladore and Alberto Merlo and N Giuliotto and Renato Talamini and Silvio Monfardini},
  journal={European urology},
  year={1996},
  volume={29 4},
  pages={434-8}
}
OBJECTIVE The effectiveness of a chemotherapy regimen including cisplatin, epirubicin, and estramustine phosphate was evaluated in a series of young patients with prostate cancer. METHODS 28 patients with a histological diagnosis of prostatic carcinoma, age < 70 years, performance status (PS) < 2, hormone-refractory status, life expectancy > 3 months… CONTINUE READING